137 related articles for article (PubMed ID: 16091933)
1. Tripeptide tyroserleutide enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1beta, TNF-alpha, and NO in vitro.
Yao Z; Qiu S; Wang L; Lu R; Zhou CL; Zhao PP; Li HQ; Gao WY
Cancer Immunol Immunother; 2006 Jan; 55(1):56-60. PubMed ID: 16091933
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell.
Yao Z; Che XC; Lu R; Zheng MN; Zhu ZF; Li JP; Jian X; Shi LX; Liu JY; Gao WY
Mol Med; 2007; 13(1-2):14-21. PubMed ID: 17515953
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of the inhibition of human hepatocarcinoma Bel7402 cells by the tripeptide tyroserleutide(YSL).
Lu R; Jia J; Bao L; Fu Z; Li G; Wang S; Wang Z; Jin M; Gao W; Yao Z
Cancer Chemother Pharmacol; 2006 Jan; 57(2):248-56. PubMed ID: 16028100
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay.
Li XL; Liu JY; Lu R; Xu Q; Zhu ZF; Wang L; Zhou CL; Jia J; Fu Z; Yao Z
Invest New Drugs; 2008 Dec; 26(6):525-9. PubMed ID: 18264678
[TBL] [Abstract][Full Text] [Related]
6. Effects of a novel tripeptide, tyroserleutide (YSL), on cell cycle progression of human hepatocellular carcinoma.
Wang C; Wang S; Lu R; Zhao L; Zhu ZF; Xu Q; Lv JQ; Wang LL; Fu Z; Lin G; Yao Z
Anticancer Drugs; 2009 Aug; 20(7):534-42. PubMed ID: 19491661
[TBL] [Abstract][Full Text] [Related]
7. The effect of tripeptide tyroserleutide (YSL) on animal models of hepatocarcinoma.
Yao Z; Lu R; Jia J; Zhao P; Yang J; Zheng M; Lu J; Jin M; Yang H; Gao W
Peptides; 2006 Jun; 27(6):1167-72. PubMed ID: 16129512
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme).
Kim YM; Talanian RV; Li J; Billiar TR
J Immunol; 1998 Oct; 161(8):4122-8. PubMed ID: 9780184
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of TNF-alpha, IL-1beta and nitrite release from mouse cultured spleen cells and lavaged peritoneal cells by mastoparan M.
Wu TM; Chou TC; Ding YA; Li ML
Immunol Cell Biol; 1999 Dec; 77(6):476-82. PubMed ID: 10571667
[TBL] [Abstract][Full Text] [Related]
10. A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice.
Jia JB; Wang WQ; Sun HC; Liu L; Zhu XD; Kong LQ; Chai ZT; Zhang W; Zhang JB; Xu HX; Zeng ZC; Wu WZ; Wang L; Tang ZY
Invest New Drugs; 2011 Oct; 29(5):861-72. PubMed ID: 20414698
[TBL] [Abstract][Full Text] [Related]
11. In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway.
Biswas SK; Sodhi A
J Interferon Cytokine Res; 2002 May; 22(5):527-38. PubMed ID: 12060491
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin.
Qureshi AA; Tan X; Reis JC; Badr MZ; Papasian CJ; Morrison DC; Qureshi N
Lipids Health Dis; 2011 Dec; 10():239. PubMed ID: 22185406
[TBL] [Abstract][Full Text] [Related]
14. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens.
Chelvarajan RL; Collins SM; Doubinskaia IE; Goes S; Van Willigen J; Flanagan D; De Villiers WJ; Bryson JS; Bondada S
J Leukoc Biol; 2004 Jun; 75(6):982-94. PubMed ID: 14982942
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor.
Qureshi AA; Guan XQ; Reis JC; Papasian CJ; Jabre S; Morrison DC; Qureshi N
Lipids Health Dis; 2012 Jul; 11():76. PubMed ID: 22698256
[TBL] [Abstract][Full Text] [Related]
16. Scavenger receptor-mediated delivery of muramyl dipeptide activates antitumor efficacy of macrophages by enhanced secretion of tumor-suppressive cytokines.
Srividya S; Roy RP; Basu SK; Mukhopadhyay A
J Leukoc Biol; 2000 May; 67(5):683-90. PubMed ID: 10811009
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-α and interleukin-1β expression pathway induced by Streptococcus mutans in macrophage cell line RAW 264.7.
Kim JS; Kim KD; Na HS; Jeong SY; Park HR; Kim S; Chung J
Mol Oral Microbiol; 2012 Jun; 27(3):149-59. PubMed ID: 22520385
[TBL] [Abstract][Full Text] [Related]
18. Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation.
Zhu ZF; Chen LJ; Lu R; Jia J; Liang Y; Xu Q; Zhou CL; Wang L; Wang S; Yao Z
BMC Cancer; 2008 Nov; 8():342. PubMed ID: 19025669
[TBL] [Abstract][Full Text] [Related]
19. Babesia bovis-stimulated macrophages express interleukin-1beta, interleukin-12, tumor necrosis factor alpha, and nitric oxide and inhibit parasite replication in vitro.
Shoda LK; Palmer GH; Florin-Christensen J; Florin-Christensen M; Godson DL; Brown WC
Infect Immun; 2000 Sep; 68(9):5139-45. PubMed ID: 10948137
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory potential of pyocyanin in LPS-stimulated murine macrophages.
Marreiro de Sales-Neto J; Lima ÉA; Cavalcante-Silva LHA; Vasconcelos U; Rodrigues-Mascarenhas S
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):102-108. PubMed ID: 30623710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
